Analystreport

Regulus Therapeutics Inc (NASDAQ: RGLS) had its "hold" rating re-affirmed by analysts at Wedbush. They now have a $1.00 price target on the stock.

Regulus Therapeutics Inc.  (RGLS) 
Last regulus therapeutics inc. earnings: 3/12 04:37 pm Check Earnings Report
US:NASDAQ Investor Relations: regulusrx.com/investors